Health Care [ 4/12 ] | Pharmaceuticals [ 14/72 ]
NASDAQ | Common Stock
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of rare and neurologic diseases in the United States.
Its lead product candidate includes AJ201, which in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous (IV) Tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders.
Avenue Therapeutics, Inc. was incorporated in 2015 and is based in Tampa, Florida.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jun 24, 24 | -15.40 Decreased by -1.04 K% | -9.00 Decreased by -71.11% |
| Mar 18, 24 | 0.06 Increased by +108.00% | -0.10 Increased by +160.00% |
| Nov 13, 23 | 0.06 Increased by +113.28% | -0.26 Increased by +123.08% |
| Aug 10, 23 | -0.52 Decreased by -1.63 K% | -0.29 Decreased by -79.31% |
| May 12, 23 | -1.35 Decreased by -2.60 K% | -0.13 Decreased by -938.46% |
| Mar 31, 23 | -0.75 Decreased by -1.40 K% | -0.15 Decreased by -400.00% |
| Nov 9, 22 | -0.45 Increased by +39.77% | -0.60 Increased by +24.72% |
| Aug 14, 22 | -0.03 Increased by +96.67% | -0.60 Increased by +95.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 0.00 Decreased by N/A% | 526.00 K Increased by +179.70% | Increased by +N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -4.01 M Decreased by -564.51% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -8.71 M Decreased by -204.83% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | 5.01 M Increased by +649.18% | Increased by +N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -660.00 K Increased by +24.23% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -603.00 K Increased by +36.46% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -2.86 M Decreased by -186.27% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 0.00 Decreased by N/A% | -913.00 K Increased by +8.06% | Decreased by N/A% Decreased by N/A% |